<DOC>
	<DOCNO>NCT01034683</DOCNO>
	<brief_summary>The purpose study evaluate efficacy toxicity lobaplatin , 5-fluorouracil ( 5-FU ) leucovorin patient esophageal carcinoma .</brief_summary>
	<brief_title>Study Lobaplatin，5-Fluorouracil Leucovorin Treatment Esophageal Carcinoma</brief_title>
	<detailed_description>patient metastatic recurrent esophageal cancer particularly poor prognosis .The overall 5-year survival rate patient newly diagnose esophageal cancer 10 % . Metastatic esophageal carcinoma incurable disease due lack effective therapy manage disease , median survival 6 8 month Chemotherapy one effective treatment far used part combine modality therapy locally advanced disease palliative treatment metastatic diseases.Lobaplatin third generation platinum.Phase Ⅱclinical trial indicate lobaplatin effective esophageal cancer , ovarian cancer , breast cancer small cell lung cancer .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically proven squamous cell carcinoma esophagus ( include cardiac cancer ) Newly diagnose patient unable unwilling surgery Recurrence surgery must adjuvant chemotherapy radiotherapy allow Patients require dimensionally measurable disease , objective measurable focus : preferably use spiral compute tomography ( CT ) measurement maximum diameter≥1cm . Cooperative Oncology Group performance status 02 KPS score ≥60 , survival time ≥3 month Neutrophils ( ANC ) ≥1.5×109/L ; blood platelet count ( BPC ) ≥80×109/L Hemoglobin ( Hgb ) ≥90g/L , serum total bilirubin ≤1.0 time upper normal limit ( ULN ) : alanine aminotransferase glutamicoxalacetic transaminase ( ALT AST ) ≤2.5 ULN Serum creatinine ( Cr ) ≤1.5ULN pregnant nursing woman ; Female patient childbearing age , without take effective contraceptive method ; patient pathologic confirmation type tumor ( eg , leiomyosarcoma , malignant lymphoma ) rather esophageal cancer ; patient tumor esophageal cancer , except cervical carcinoma situ skin basal cancer squamous cell carcinoma receive adequate treatment ; patient cerebral meningeal metastasis , intestinal obstruction , symptomatic pathologic change peripheral nerve , NCICCTG standard &gt; grade 2 patient serious complication : serious heart disease remain unstable treatment , myocardial infarction , congestive heart failure , unstable angina , frank pericardial effusion unstable arrhythmias 6 month enrol group ; confirm neuropathy psychosis , include dementia epilepsia ; uncontrolled infection ; active disseminate intravascular coagulation ; uncontrolled diabetes , fast serum glucose &gt; 7.8mmol / L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>